ResearchSafe

Dihexa (Oral) (Dihexa (N-hexanoic-Tyr-Ile-(6) Aminohexanoic Amide))

Category: Cognitive & Nootropic. Status: Research compound.

An extremely potent cognitive enhancer that drives synaptogenesis - the formation of new synaptic connections. Reportedly 10 million times more potent than BDNF for promoting new connections. A favorite in telemedicine nootropic protocols.

How it works

Activates hepatocyte growth factor (HGF) / c-Met receptor system in the brain, triggering dendritic spine formation, synaptogenesis, and neuronal survival. This creates new neural pathways for learning and memory.

Key facts

  • Molecular weight: 507.63 Da
  • Half-life: ~12 hours
  • Bioavailability: ~70% oral, ~60% intranasal
  • Storage: Room temperature, dry and sealed.

Dosing overview

  • Typical dose: 10-20 mg
  • Frequency: Daily or every other day
  • Duration: 4-8 weeks cycled
  • Route: Oral capsule or sublingual

Protocol notes

  • Common use is ~10-20 mg/day, often dissolved in a carrier and taken sublingually or as an oil-based capsule.
  • Some dose every other day given the long half-life and unknown long-term profile.
  • Effects are subtle and cumulative - it builds new connections over weeks, not hours.

Reported benefits

  • Synaptogenesis (new brain connections)
  • Dramatic memory enhancement
  • Learning acceleration
  • Neuroprotection
  • Cognitive recovery after injury

Possible side effects

  • Headache
  • Overstimulation
  • Insomnia
  • Anxiety at high doses
  • Unknown long-term profile

Research

  • Dihexa and HGF/c-Met synaptogenesis (2020): Restored cognitive function in Alzheimer models with formation of new stable synaptic connections in hippocampus.

Compare Dihexa (Oral)

Research and educational reference only. Not medical advice.